Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis — Indianapolis, Indiana

Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis is a clinical research site located in Indianapolis, Indiana, United States 45237.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis has participated in 1 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis?

Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis conducted?

Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML), FMS-like Tyrosine Kinase-3 (FLT3) Mutations.

Is Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis accredited by Crixeo Health?

Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Indiana Blood and Marrow Transplantation at Franciscan Health Indianapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.